Artelo Biosciences, Inc. (ARTL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.87M |
| Enterprise Value | 2.95M |
| P/E Ratio | -0.08 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.34 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.16 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.96 |
| Return On Equity | -5.19 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -12.54M |
| Net Income | -12.88M |
| Diluted EPS | -49.23 |
| Total Cash | 4.2M |
| Total Cash/Share | 13.93 |
| Total Debt | 49,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3 |
| Book Value Per Share | 16.58 |
| 52-Week Change | -87.29 |
| 52-Week High | 179.19 |
| 52-Week Low | 4.68 |
| Moving Average 50 Days | 7.74 |
| Moving Average 200 Days | 29.28 |
| Average Volume | 50,517 |
| Shares Outstanding | 387,282 |
| % Held by Institutions | 4.32 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | August 31, 2026 |